BG Medicine to Present at the SG Cowen 25th Annual Health Care Conference03/10/2005Waltham, Mass. March 10, 2005 - BG Medicine, Inc., an early stage drug development company, announced today that it will participate in the SG Cowen 25th Annual Healthcare Conference to be hheld March 14-17, 2005 at the Boston Marriot Copley Place in Boston, MA. Pieter Muntendam MD, President of BG Medicine, will give the first presentation of the conference at 1:00 p.m. Eastern time, on March 14th, followed by a question and answer session. Further information about the SG Cowen Healthcare Conference please visit their website (www.sacowen.com/UpcomingConferences.asp). About BG Medicine BG Medicine is pioneering the commercial application of Systems Pharmacology, which is based on scientific advances in the Systems Biology field. Its advanced proprietary platform enables novel paths to new medicines through molecular fingerprinting of transcript, proteomic, and metabolomics data combined with powerful bioinformatics integration to produce Systems Response Profiles™. These profiles, which combine information from multiple physiological compartments and often include thousands of distinct analyte levels, have enabled unprecedented molecular characterization of disease states and drug response. BG Medicine applies its novel approach through collaborations with leading pharmaceutical companies. Founded in 2000 and located in Waltham, Mass., BG Medicine is backed by Flagship Ventures and Glide Investment Management. For more information see www.bg-medicine.com. |